Respiratory News and Research

RSS

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Nearly one in two seniors in Ontario who visited a family doctor for a non-bacterial infection received an unnecessary antibiotic prescription, according to a new study from the Institute for Clinical Evaluative Sciences Western site in London, Ontario and Lawson Health Research Institute.

9 May 2017

Peer victimization in fifth grade has lasting effects on health and later substance use, study finds

A new study led by the University of Delaware found that kids who are bullied in fifth grade often suffer from depression and begin using alcohol and other substances a few years after the incidents.

8 May 2017

FDA approves new treatment for people with ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.

5 May 2017

FDA approves new AML drug after clinical testing at Dana-Farber

A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.

5 May 2017

Scientists identify differences in outcomes for women and men with AFF in emergency departments

Atrial fibrillation and flutter (also known as AFF) is associated with serious health problems and is a significant contributor to death rates.

4 May 2017

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD), published today in the European Respiratory Journal, has revealed that both the 3-year all-cause mortality rate and financial burden for patients with the disease is almost four times higher than a matched control group.

2 May 2017

Study highlights risk factors for widespread vitamin D deficiency

Results from a clinical review published in The Journal of the American Osteopathic Association find nearly 1 billion people worldwide may have deficient or insufficient levels of vitamin D due to chronic disease and inadequate sun exposure related to sunscreen use.

2 May 2017

Different doses of resistance exercises could aid recovery from infection, injury

Having your healthcare professional prescribe you a dose of bench presses to ward off an infection or help heal an injury may sound like shonky healthcare but could actually be the advice of the near future, according to Griffith University scientists.

29 Apr 2017

ARDS survivors who return to work end up losing their jobs, study finds

Forty-four percent of people who held jobs before contracting a condition called acute respiratory distress syndrome were jobless one year after they were discharged from the hospital, costing them an average of about $27,000 in earnings.

29 Apr 2017

Study examines economic impact of surviving acute respiratory distress syndrome

According to a new multicenter study, nearly half of previously employed adult survivors of acute respiratory distress syndrome were jobless one year after hospital discharge, and are estimated to have lost an average of $27,000 in earnings.

28 Apr 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.

28 Apr 2017

Marijuana use among pregnant women linked to low birth weight infants

In a new study, researchers in London, Ontario found that women who used marijuana while pregnant were almost three times more likely to have an infant with low birth weight than women who did not use marijuana.

27 Apr 2017

Nanoparticles can travel from the lungs into bloodstream and reach susceptible areas of cardiovascular system

Tiny particles in air pollution have been associated with cardiovascular disease, which can lead to premature death. But how particles inhaled into the lungs can affect blood vessels and the heart has remained a mystery.

27 Apr 2017

Researchers aim to test asthma drug for treating patients with heart disease

Researchers at Guy's and St Thomas' NHS Foundation Trust have launched an innovative new trial which aims to improve the recovery of patients with serious heart conditions.

27 Apr 2017

New class of drugs offers hope against antibiotic resistance

Polyphor today presented promising data for their novel class of antibiotics, the Outer Membrane Protein Targeting Antibiotics (OMPTA). This is the first new class of antibiotic against Gram-negative pathogens to reach advanced clinical development in over 40 years.

26 Apr 2017

Epigenetic changes detectable at birth linked to risk of obesity

These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.

26 Apr 2017

Cold weather increases risk of mortality in Texas, study finds

Cold weather increases the risk of mortality in Texas residents, according to researchers at The University of Texas Health Science Center at Houston School of Public Health. The findings were recently published in the journal Environmental Pollution.

26 Apr 2017

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

25 Apr 2017

Return of malaria in the U.S. is costing millions, study claims

Malaria-related hospitalizations and deaths in the U.S. are far more common than expected, report researchers, despite transmission having been eliminated in the country back in the 1950s.

25 Apr 2017

Respiratory News and Research

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Peer victimization in fifth grade has lasting effects on health and later substance use, study finds

FDA approves new treatment for people with ALS

FDA approves new AML drug after clinical testing at Dana-Farber

Scientists identify differences in outcomes for women and men with AFF in emergency departments

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

Study highlights risk factors for widespread vitamin D deficiency

Different doses of resistance exercises could aid recovery from infection, injury

ARDS survivors who return to work end up losing their jobs, study finds

Study examines economic impact of surviving acute respiratory distress syndrome

Takeda announces accelerated approval from FDA for new lung cancer treatment

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Marijuana use among pregnant women linked to low birth weight infants

Nanoparticles can travel from the lungs into bloodstream and reach susceptible areas of cardiovascular system

Researchers aim to test asthma drug for treating patients with heart disease

New class of drugs offers hope against antibiotic resistance

Epigenetic changes detectable at birth linked to risk of obesity

Cold weather increases risk of mortality in Texas, study finds

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Return of malaria in the U.S. is costing millions, study claims

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News